News CEPI steps in to fund Moderna's pandemic flu jab Thanks to CEPI, Moderna's H5 bird flu vaccine can start a pivotal trial shelved after funding for the jab was pulled in the US by HHS Sec Kennedy.
News White House retreats from block on NIH research funding A move by the Trump administration to block NIH research funding for external research teams appears to have been abandoned.
News Novo Nordisk Foundation gives $75m for R&D 'challenges' The Novo Nordisk Foundation's latest round of R&D funding will go towards projects in biomanufacturing, cardiometabolic diseases, and AI.
News Moderna's $760m-plus flu vaccine contracts are nixed by HHS HHS cancels funding for Moderna's pandemic flu vaccine development in a move viewed by some as an attack on mRNA technology.
News EU joins the bid to court beleaguered US scientists The EU has announced a €500m scheme to convince scientific talent from around the world to relocate to Europe's "free and open" research environment.
News NIH is pulling the plug on foreign research grants A new policy from the NIH in the US will cut billions of dollars of funding for research organisations and hospitals outside the US.
News FDA approves higher Wegovy dose via 4th priority voucher The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.